GDN-1801

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameGDN-1801
Drug Alias NameGD-N1801GDN1801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesWound Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSichuan Gooddoctor Panxi Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLuoxin Aurovitas Pharma Chengdu Co LtdSichuan Gooddoctor Panxi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesWound Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A